In recent years, the high-mobility group box 1 (HMGB1)/receptor for advanced glycation end products (RAGE) signaling pathway has emerged as a promising target for therapeutic interventions in cerebral ischemia [2]. Here, HMGB1 is linked to brain ischemia.